Free Trial
NASDAQ:HYPR

Hyperfine Q1 2025 Earnings Report

Hyperfine logo
$0.70 -0.04 (-5.05%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$0.69 -0.01 (-1.62%)
As of 09:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hyperfine EPS Results

Actual EPS
N/A
Consensus EPS
-$0.12
Beat/Miss
N/A
One Year Ago EPS
N/A

Hyperfine Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.82 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Hyperfine Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Monday, May 12, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Remove Ads

Hyperfine Earnings Headlines

REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
Hyperfine initiated with a Buy at Lake Street
Hyperfine price target lowered to $1.20 from $1.50 at B. Riley
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR), a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

View Hyperfine Profile

More Earnings Resources from MarketBeat